Antifungal Immunity and the Mechanism of Fungal Programmed Cell Death
抗真菌免疫和真菌程序性细胞死亡机制
基本信息
- 批准号:10079460
- 负责人:
- 金额:$ 65.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-01-22 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:Antifungal AgentsApoptosisApoptosis InhibitorApoptosis Regulation GeneApoptoticApplications GrantsAspergillosisAspergillus fumigatusAspergillus nidulansBIR DomainBaculovirusesBiochemicalBiochemistryBiological ModelsCandida albicansCandidiasisCartoonsCaspaseCell DeathCell Death InductionCellsCollaborationsComplementDNA FragmentationDataDefectDevelopmentDiseaseDisease OutcomeEnzymesEssential GenesEtiologyEukaryotaFamilyFungal GenesFungal ProteinsFungal SporesGeneticGenetic studyGerminationGoalsHistonesHost DefenseHumanHyphaeImmuneImmunityImmunologic SurveillanceImmunologicsImmunologyInduction of ApoptosisInhalationInnate Immune SystemKnowledgeLaboratoriesLungMediatingModelingMoldsMyelogenousNADPH OxidaseOxidative StressPathogenesisPathway interactionsPatient-Focused OutcomesPatientsPhagocytesPharmacologyPharmacology StudyPhysiologyPlayPneumoniaPost-Translational RegulationPredispositionProcessProteinsRegulationReporterReportingReproduction sporesResearch PersonnelResistanceRespiratory BurstRoleStressSystemTertiary Protein StructureTestingTherapeuticTissuesVirulenceVisualizationWorkbaseexperiencefungal geneticsimmune checkpointimmune functionimprovedin vivoinnovationinsightmembernew therapeutic targetnovelnovel therapeutic interventionpathogenic funguspredictive modelingpreventrespiratoryresponse
项目摘要
PROJECT SUMMARY
Humans inhale fungal conidia (i.e, vegetative spores) on a daily basis. The ability of the respiratory innate
immune system to prevent germination of inhaled conidia into tissue-invasive hyphae represents a critical
immunologic checkpoint. Using Aspergillus fumigatus, the most common etiologic agent of invasive
aspergillosis, as a model system for human fungal pathogens, we discovered that conidia undergo
programmed cell death with apoptosis-like features during interactions with innate immune cells. This finding
was facilitated by a novel fluorescent reporter of fungal physiology that enables visualization and quantitation
of fungal apoptosis markers, including histone degradation, caspase activation, and DNA fragmentation.
Our work demonstrates that A. fumigatus conidia express an essential and druggable anti-apoptotic protein,
termed Bir1, that counters host induction of apoptosis-like programmed cell death by the action of phagocyte
NADPH oxidase. Genetic and pharmacologic studies demonstrate that Bir1 expression and activity underlie
conidial susceptibility to host apoptosis-like programmed cell death, and in turn, host susceptibility to invasive
aspergillosis. These findings indicate that mammalian fungal immune surveillance exploits a fungal apoptosis-
like programmed cell death pathway to maintain barrier immunity in the lung.
In this collaborative proposal with two co-investigators, we seek to determine the mechanism through which
Bir1 regulates anti-apoptotic activity during fungal-host cell encounters. Our preliminary data support a model
in which Bir1 exerts anti-apoptotic activity via two conserved BIR domains, underlies post-translational
regulation in response to pro-apoptotic stress, regulates candidate fungal caspase-like enzymes as apoptosis
effectors, and demonstrates functional conservation across human pathogenic fungi. Based on these
observations, our model predicts that fungal apoptosis-like programmed cell death is a general feature of
fungal-host cell encounters and central to the establishment of invasive fungal disease. We explore this model
in the following aims: (1) define the functional domains and post-translational regulation of Bir1 critical for
resistance to host induction of apoptosis-like programmed cell death, (2) define the mechanism of Bir1-
mediated resistance to host induction of apoptosis-like programmed cell death, with an emphasis on regulation
of a candidate fungal caspase-like activity, and (3) define the role of apoptosis-like programmed cell death and
Bir1 homologs following Aspergillus nidulans and Candida albicans challenge. The proposed studies are
significant and innovative because they identify a novel mechanism of immune surveillance and demonstrate
that higher eukaryotes can exploit programmed cell death in lower eukaryotes for the purpose of sterilizing
immunity. This work will provide a mechanistic understanding of Bir1 function in regulating host-fungal
encounters. Knowledge gained from these studies will inform strategies that target fungal Bir1 homologs and
exploit fungal apoptosis-like programmed cell death for therapeutic gain.
项目概要
人类每天吸入真菌分生孢子(即营养孢子)。与生俱来的呼吸能力
免疫系统防止吸入的分生孢子萌发为组织侵入性菌丝是一个关键
免疫检查点。使用烟曲霉(最常见的侵袭性病原体)
曲霉病作为人类真菌病原体的模型系统,我们发现分生孢子经历
在与先天免疫细胞相互作用期间具有类似凋亡特征的程序性细胞死亡。这一发现
一种新型的真菌生理学荧光报告基因促进了可视化和定量
真菌凋亡标志物,包括组蛋白降解、半胱天冬酶激活和 DNA 片段化。
我们的工作表明,烟曲霉分生孢子表达一种必需的、可药物化的抗凋亡蛋白,
称为 Bir1,通过吞噬细胞的作用对抗宿主诱导的细胞凋亡样程序性细胞死亡
NADPH 氧化酶。遗传和药理学研究表明 Bir1 表达和活性是
分生孢子对宿主细胞凋亡样程序性细胞死亡的易感性,反过来,宿主对侵入性的易感性
曲霉病。这些发现表明哺乳动物的真菌免疫监视利用了真菌细胞凋亡-
像程序性细胞死亡途径一样维持肺部的屏障免疫。
在这项与两名联合研究者的合作提案中,我们寻求确定一种机制,通过该机制
Bir1 在真菌与宿主细胞相遇期间调节抗凋亡活性。我们的初步数据支持模型
其中 Bir1 通过两个保守的 BIR 结构域发挥抗凋亡活性,是翻译后调控的基础
响应促凋亡应激的调节,调节候选真菌半胱天冬酶样酶作为凋亡
效应器,并展示了人类病原真菌的功能保守性。基于这些
根据观察,我们的模型预测真菌凋亡样程序性细胞死亡是真菌的一个普遍特征
真菌与宿主细胞的相遇对于侵袭性真菌病的形成至关重要。我们探索这个模型
目标如下:(1) 定义 Bir1 的功能域和翻译后调控,这对于
抵抗宿主诱导的凋亡样程序性细胞死亡,(2)定义Bir1-的机制
介导对宿主诱导的凋亡样程序性细胞死亡的抵抗,重点是调节
候选真菌半胱天冬酶样活性的作用,以及(3)定义凋亡样程序性细胞死亡的作用和
构巢曲霉和白色念珠菌攻击后的 Bir1 同源物。拟议的研究是
意义重大且具有创新性,因为他们确定了一种新的免疫监视机制并证明了
高等真核生物可以利用低等真核生物的程序性细胞死亡来达到绝育的目的
免疫。这项工作将从机制上理解 Bir1 在调节宿主真菌中的功能
遭遇。从这些研究中获得的知识将为针对真菌 Bir1 同源物和
利用真菌凋亡样程序性细胞死亡来获得治疗效果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert Andrew Cramer其他文献
Robert Andrew Cramer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert Andrew Cramer', 18)}}的其他基金
Antifungal Immunity and the Mechanism of Fungal Programmed Cell Death
抗真菌免疫和真菌程序性细胞死亡机制
- 批准号:
10538624 - 财政年份:2019
- 资助金额:
$ 65.3万 - 项目类别:
Environmental Oxygen Transitions and Aspergillosis Disease Progression
环境氧转变和曲霉病进展
- 批准号:
10615129 - 财政年份:2019
- 资助金额:
$ 65.3万 - 项目类别:
Environmental Oxygen Transitions and Aspergillosis Disease Progression
环境氧转变和曲霉病进展
- 批准号:
10404535 - 财政年份:2019
- 资助金额:
$ 65.3万 - 项目类别:
Antifungal Immunity and the Mechanism of Fungal Programmed Cell Death
抗真菌免疫和真菌程序性细胞死亡机制
- 批准号:
10320401 - 财政年份:2019
- 资助金额:
$ 65.3万 - 项目类别:
Overcoming Emerging Aspergillus fumigatus Azole Resistance Via Protease Inhibition
通过蛋白酶抑制克服新出现的烟曲霉唑抗性
- 批准号:
10547781 - 财政年份:2019
- 资助金额:
$ 65.3万 - 项目类别:
Environmental Oxygen Transitions and Aspergillosis Disease Progression
环境氧转变和曲霉病进展
- 批准号:
10161719 - 财政年份:2019
- 资助金额:
$ 65.3万 - 项目类别:
Overcoming Emerging Aspergillus fumigatus Azole Resistance Via Protease Inhibition
通过蛋白酶抑制克服新出现的烟曲霉唑抗性
- 批准号:
10334562 - 财政年份:2019
- 资助金额:
$ 65.3万 - 项目类别:
Overcoming Emerging Aspergillus fumigatus Azole Resistance Via Protease Inhibition
通过蛋白酶抑制克服新出现的烟曲霉唑抗性
- 批准号:
10320260 - 财政年份:2019
- 资助金额:
$ 65.3万 - 项目类别:
相似国自然基金
BCL-2抑制剂在骨髓增生异常综合征中靶向自噬触发细胞凋亡的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Sglt2抑制剂达格列净减轻NBCe1诱导的心肌细胞钙稳态失衡和凋亡而改善心衰的机制研究
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
中药单体改构药CP5322促进急性髓系白血病细胞凋亡及其机制研究
- 批准号:82000161
- 批准年份:2020
- 资助金额:8.0 万元
- 项目类别:青年科学基金项目
ROCK抑制剂对实验性近视合并OPTN(E50K)突变致RGCs凋亡巩膜成纤维细胞表型转化中的作用及机制研究
- 批准号:82000889
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
- 批准号:31900527
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Impact of SARS-CoV-2 Immune Dysregulation on Antifungal Immunity
SARS-CoV-2 免疫失调对抗真菌免疫的影响
- 批准号:
10658355 - 财政年份:2023
- 资助金额:
$ 65.3万 - 项目类别:
Long-acting formulations of griseofulvin for ocular neovascularization therapy
用于眼部新生血管治疗的灰黄霉素长效制剂
- 批准号:
10682059 - 财政年份:2023
- 资助金额:
$ 65.3万 - 项目类别:
Improving granulocyte transfusion in neutropenia-related infections
改善中性粒细胞减少相关感染的粒细胞输注
- 批准号:
10494384 - 财政年份:2022
- 资助金额:
$ 65.3万 - 项目类别:
Conservation of programmed cell death across species
跨物种程序性细胞死亡的保守性
- 批准号:
10640365 - 财政年份:2022
- 资助金额:
$ 65.3万 - 项目类别:
Improving granulocyte transfusion in neutropenia-related infections
改善中性粒细胞减少相关感染的粒细胞输注
- 批准号:
10682602 - 财政年份:2022
- 资助金额:
$ 65.3万 - 项目类别: